Inventor
VILLEMURE ELISIA
US16 patents
⚠️ This page may combine multiple inventors who share the name “VILLEMURE ELISIA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GENENTECH INC
14 patentsUS10179782B2Jan 15, 2019
Substituted sulfonamide compounds
GENENTECH INC5 citations72
US10710994B2Jul 14, 2020
Oxadiazole transient receptor potential channel inhibitors
GENENTECH INC3 citations68
US12202824B2Jan 21, 2025
Oxadiazole transient receptor potential channel inhibitors
GENENTECH INC0 citations58
US11655245B2May 23, 2023
Oxadiazole transient receptor potential channel inhibitors
GENENTECH INC0 citations58
US12428419B2Sep 30, 2025
Therapeutic compounds
GENENTECH INC0 citations56
US11993599B2May 28, 2024
Therapeutic compounds
GENENTECH INC0 citations56
US12459957B2Nov 4, 2025
Therapeutic compounds and methods
GENENTECH INC0 citations55
US12006331B2Jun 11, 2024
Therapeutic compounds and methods
GENENTECH INC1 citations55
US10647731B2May 12, 2020
Thiazolopyrimidinones and methods of use thereof
GENENTECH INC0 citations51
US9988400B2Jun 5, 2018
Thiazolopyrimidinones and methods of use thereof
GENENTECH INC0 citations51
US10913742B2Feb 9, 2021
Oxadiazolones as transient receptor potential channel inhibitors
GENENTECH INC0 citations50
US12338256B2Jun 24, 2025
Aza-tetracyclic oxazepine compounds and uses thereof
GENENTECH INC0 citations44
US10280165B2May 7, 2019
Pyridopyrimidinones and methods of use thereof
GENENTECH INC0 citations39
US10711004B2Jul 14, 2020
Oxadiazole transient receptor potential channel inhibitors
GENENTECH INC0 citations37